Jonathan C. Javitt - Chairman and Chief Scientist, Director, 10%+ Owner at NRX Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman and Chief Scientist, Director, 10%+ Owner
Issuer Symbol
NRXP, NRXPW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jonathan C. Javitt since 11 Mar 2025

Holdings reported by Jonathan C. Javitt for NRX Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,260,000 $1,474,200 $1.17 17 Dec 2024 By the Jonathan Javitt Living Trust
Common Stock 142,200 $166,374 $1.17 17 Dec 2024 By the Javitt 2012 Irrevocable Dynasty Trust
Common Stock 84,634 $99,022 $1.17 17 Dec 2024 Direct
Common Stock 30,000 $35,100 $1.17 17 Dec 2024 By the Jonathan Javitt Donor Advised Fund
Stock Option (right to buy) 125,000 09 Apr 2025 Direct Common Stock

Transactions reported by Jonathan C. Javitt for NRX Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.